Venn Life Sciences Holdings PLC (LON:VENN – Get Free Report) shares passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 6.85 ($0.08) and traded as low as GBX 6.70 ($0.08). Venn Life Sciences shares last traded at GBX 6.85 ($0.08), with a volume of 1,027,544 shares changing hands.
Venn Life Sciences Price Performance
The company’s 50 day moving average price is GBX 6.85 and its 200 day moving average price is GBX 6.85. The firm has a market capitalization of £4.89 million and a P/E ratio of -2.14. The company has a debt-to-equity ratio of 35.83, a current ratio of 2.30 and a quick ratio of 1.48.
About Venn Life Sciences
Venn Life Sciences Holdings Plc, a clinical research organization, provides consulting and clinical trial services to pharmaceutical, biotechnology, and medical device companies in the United Kingdom, Ireland, France, the Netherlands, Germany, and Singapore. The company offers drug development planning and strategy services, including clinical feasibility assessment, project management, and in-licensing and technical due diligence; and early drug development services, such as drug candidate selection, CMC, non-clinical/pre-clinical development, clinical pharmacology, pharmacokinetics, and pharmacometrics and PK-PD modelling.
Read More
- Five stocks we like better than Venn Life Sciences
- Dividend Capture Strategy: What You Need to Know
- 3 Stocks Leading the U.S. Agriculture Comeback
- What Are the FAANG Stocks and Are They Good Investments?
- How to Use Put Debit Spreads to Profit From Falling Stocks
- About the Markup Calculator
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for Venn Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venn Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
